Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
Acq. announced
|
|
OPTIMER PHARMACEUTICALS INC (OPTR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/24/2012 |
8-K
| Form 8-K - Current report |
| 01/10/2011 |
8-K
| Form 8-K - Current report |
| 05/06/2010 |
8-K
| Appointed a new director|
Docs:
|
"Offer Letter, by and between Mr. Pedro Lichtinger and Optimer Pharmaceuticals, Inc",
"Separation and Consulting Agreement, by and between Dr. Michael Chang and Optimer Pharmaceuticals, Inc",
"Optimer Pharmaceuticals, Inc. Amended and Restated Severance Benefit Plan",
"Optimer Pharmaceuticals Appoints Pedro Lichtinger as President and CEO to Succeed Michael N. Chang, Ph.D., Who Will Serve as Chairman of the Board" |
|
| 12/04/2009 |
8-K
| Form 8-K - Current report |
| 02/24/2009 |
8-K
| Form 8-K -- Current report |
|
|